Neurocrine Biosciences
NBIX
#1507
Rank
HK$100.29 B
Marketcap
HK$1,013
Share price
-0.22%
Change (1 day)
-6.73%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Total assets

Total assets on the balance sheet as of March 2025 : HK$28.94 Billion

According to Neurocrine Biosciences 's latest financial reports the company's total assets are HK$28.94 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Neurocrine Biosciences - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31HK$28.87 B13.69%
2023-12-31HK$25.39 B37.21%
2022-12-31HK$18.50 B14.52%
2021-12-31HK$16.16 B20.17%
2020-12-31HK$13.44 B32.21%
2019-12-31HK$10.17 B30.78%
2018-12-31HK$7.77 B21.75%
2017-12-31HK$6.38 B125.63%
2016-12-31HK$2.83 B-23.07%
2015-12-31HK$3.67 B95.21%
2014-12-31HK$1.88 B57.17%
2013-12-31HK$1.19 B-21.04%
2012-12-31HK$1.51 B41.35%
2011-12-31HK$1.07 B-4.38%
2010-12-31HK$1.12 B104.69%
2009-12-31HK$0.54 B-39.87%
2008-12-31HK$0.91 B-57.66%
2007-12-31HK$2.15 B-28.83%
2006-12-31HK$3.03 B-19.09%
2005-12-31HK$3.74 B-7.17%
2004-12-31HK$4.03 B-6.2%
2003-12-31HK$4.30 B106.94%
2002-12-31HK$2.07 B-23.03%
2001-12-31HK$2.70 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Repligen
RGEN
HK$22.38 B-22.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
HK$138.21 B 377.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
Palatin Technologies
PTN
HK$29.26 M-99.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$701.66 B 2,323.97%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$1.068 T 3,592.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$1.632 T 5,541.13%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
HK$10.14 B-64.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
HK$58.3 M-99.80%๐Ÿ‡บ๐Ÿ‡ธ USA